The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
NACompletedINTERVENTIONAL
Enrollment
228
Participants
Timeline
Start Date
June 1, 2016
Primary Completion Date
January 31, 2017
Study Completion Date
January 31, 2017
Conditions
Hepatitis BInterferon
Interventions
DRUG
Interferon
Interferon
DRUG
Interferon+resveratrol
Interferon+resveratrol
All Listed Sponsors
lead
The First Hospital of Jilin University
OTHER
NCT03546530 - The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients | Biotech Hunter | Biotech Hunter